VISA-P (Patellar Tendinopathy)

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۱۰

حداقل ۰ — حداکثر ۱۰

حداقل ۰ — حداکثر ۱۰

حداقل ۰ — حداکثر ۱۰

حداقل ۰ — حداکثر ۱۰

حداقل ۰ — حداکثر ۱۰

حداقل ۰ — حداکثر ۱۰

حداقل ۰ — حداکثر ۱۲۰

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
visa p total
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Recorded0–100
Direct Clinical Answer

The VISA-P (Patellar Tendinopathy) calculates calculating standardized physiological indices and stratifying general clinical risk. Key inputs include q1 sitting. Scores guide individualizing bedside clinical management, scheduling routine follow-up, and monitoring clinical progress. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Victorian Institute of Sport Assessment-Patella (VISA-P, Visentini 1998): 8-item severity index for patellar tendinopathy (jumper's knee), parallel in structure to VISA-A. Questions 1-7 scored 0-10; question 8 (sport participation) 0-30/20/10 by subgroup. Total 0-100; higher = milder symptoms.

Clinical Indication

The VISA-P (Patellar Tendinopathy) is indicated for bedside clinical practice to support Victorian Institute of Sport Assessment-Patella (VISA-P, Visentini 1998): 8-item severity index for patellar tendinopathy (jumper's knee), parallel in structure to VISA-A. Questions 1-7 scored 0-10; question 8 (sport participation) 0-30/20/10 by subgroup. Total 0-100; higher = milder symptoms.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult ambulatory and hospitalized patient cohorts evaluated for systemic illness, physiologic risk, or diagnostic probability. Clinical application is indicated across General medical-surgical inpatient units, primary care clinics, and ambulatory outpatient facilities.

Limitations & Contraindications

Single-point score values can obscure rapid temporal clinical deterioration; serial clinical reassessment is essential.

Clinical Pearls & Action Plan

Calculated indices must be contextualized alongside complete clinical history, physical exam, and dynamic trajectory.

Formula & Variables:

VISA-P = Q1+Q2+Q3+Q4+Q5+Q6+Q7 (0-10 each) + Q8 (0-30)

Input Parameters

NameTypeRequiredDescription
q1_sittingintegerYesQ1: minutes able to sit pain-free (0-10; 10 = 100+ min)
q2_stairs_painintegerYesQ2: pain walking downstairs, normal gait (0-10; 10 = no pain)
q3_extension_painintegerYesQ3: pain with full active non-weightbearing knee extension (0-10)
q4_lunge_painintegerYesQ4: pain with full weightbearing lunge (0-10)
q5_squatintegerYesQ5: problems squatting (0-10; 10 = no problems)
q6_hops_painintegerYesQ6: pain during/after 10 single-leg hops (0-10)
q7_activityintegerYesQ7: current sport/activity level (0-10; 10 = full competition)
q8_groupstringYesQ8 subgroup: A (no pain in sport), B (some pain, completes), C (pain stops sport)
q8_minutesintegerYesQ8: training/practice minutes (capped by subgroup max)

Score Interpretation & Guidance

RangeStageDescription
0–100RecordedVISA-P total score

Evidence-Based References (EBM)

  • Visentini PJ, Khan KM, Cook JL, Kiss ZS, Harcourt PR, Wark JD. The VISA score: an index of severity of symptoms in patients with jumper's knee (patellar tendinosis). J Sci Med Sport. 1998;1(1):22-28.

Related calculators